HLAVNÍ TÉMA Telemedicína v diabetologii | 153 / Vnitř Lék. 2022;68(3):144-152 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz rozšířit možnosti péče o pacienty s diabetem a jeho komplikacemi, vede k přesvědčivému zlepšení kompenzace diabetu a ke zlepšení selfmonitoringu pacientů s diabetem. Pozitivní účinek telemedicíny závisí na správném nastavení procesů přenosu a zpracování dat, ale také na edukaci všech zúčastněných. Telemedicína podporuje zapojení pacientů, ale i dalších zdravotníků do managementu diabetu, zlepšuje koordinaci péče a zefektivňuje komunikaci mezi pacienty a zdravotníky. Podpořeno MZ ČR – RVO („Institut klinické a experimentální medicíny – IKEM, IČ 00023001“). LITERATURA 1. Chan JCN, LimLL, WarehamNJ, Shaw JE, Orchard TJ, Zhang P et al. The Lancet Commission on diabetes: using data to transformdiabetes care and patient lives. Lancet. 2021;396(10267):201982. 2. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available from: https://www.diabetesatlas.org 3. Borries TM, Dunbar A, Bhukhen A, Rismany J, Kilham J, Feinn R et al. The impact of telemedicine on patient self‑management processes and clinical outcomes for patients with Types I or II Diabetes Mellitus in the United States: A scoping review. Diabetes Metab Syndr. 2019;13(2):1353-7. 4. McDonnell ME. Telemedicine in Complex Diabetes Management. Curr Diab Rep. 2018;18(7):42. 5. Shan R, Sarkar S, Martin SS. Digital health technology and mobile devices for the management of diabetes mellitus: state of the art. Diabetologia. 2019;62(6):877-87. 6. Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth Interventions to Support Self‑Management of Long‑Term Conditions: A Systematic Metareview of Diabetes, Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, and Cancer. J Med Internet Res. 2017;19(5):e172. 7. Fagherazzi G, Ravaud P. Digital diabetes: Perspectives for diabetes prevention, management and research. Diabetes Metab. 2019;45(4):322-9. 8. Andres E, Meyer L, Zulfiqar AA, HajjamM, Talha S, Bahougne T et al. Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies. J Med Life. 2019;12(3):203-14. 9. Greenwood DA, Gee PM, Fatkin KJ, Peeple MA. Systematic Review of Reviews Evaluating Technology‑Enabled Diabetes Self‑Management Education and Support. J Diabetes Sci Technol. 2017;11(5):1015-27. 10. Garg S, Norman GJ. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real‑Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic. Diabetes Technol Ther. 2021;23(S1):S15-S20. 11. Nguyen OT, Alishahi Tabriz A, Huo J, Hanna K, Shea CM, Turner K. Impact of Asynchronous Electronic Communication‑Based Visits on Clinical Outcomes and Health Care Delivery: Systematic Review. J Med Internet Res. 2021;23(5):e27531. 12. Heinemann L, Schnell O, Gehr B, Schloot NC, Gorgens SW, Gorgen C. Digital Diabetes Management: A Literature Review of Smart Insulin Pens. J Diabetes Sci Technol. 2021:1932296820983863. 13. Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 2017;133:178-92. 14. Wood A, O‘Neal D, Furler J, Ekinci EI. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. InternMed J. 2018;48(5):499-508. 15. Ang E, Lee ZX, Moore S, Nana M. Flash glucosemonitoring (FGM): A clinical reviewon glycaemic outcomes and impact on quality of life. J Diabetes Complications. 2020;34(6):107559. 16. Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Glycaemic management in diabetes: old and new approaches. Lancet Diabetes Endocrinol. 2022;10(1):75-84. 17. Eberle C, Stichling S. Telemetric Interventions Offer NewOpportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta‑review. JMIR Diabetes. 2021;6(1):e20270. 18. Boughton CK, Hovorka R. Newclosed‑loop insulin systems. Diabetologia. 2021;64(5):1007-15. 19. Eberle C, Lohnert M, Stichling S. Effectiveness of Disease‑SpecificmHealth Apps in Patients With Diabetes Mellitus: Scoping Review. JMIR Mhealth Uhealth. 2021;9(2):e23477. 20. Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta‑Analyses. J Med Internet Res. 2020;22(3):e16791. 21. Zhang B. Expert Consensus on Telemedicine Management of Diabetes (2020 Edition). Int J Endocrinol. 2021;2021:6643491. 22. Eze ND, Mateus C, Cravo Oliveira Hashiguchi T. Telemedicine in the OECD: An umbrella reviewof clinical and cost‑effectiveness, patient experience and implementation. PLoS One. 2020;15(8):e0237585. 23. Eberle C, Stichling S. Effects of Telemetric Interventions onMaternal and Fetal or Neonatal Outcomes in Gestational Diabetes: SystematicMeta‑Review. JMIR Diabetes. 2021;6(3):e24284. 24. Eberle C, Stichling S. Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta‑Review. J Med Internet Res. 2021;23(2):e23252. 25. Hu Y, Wen X, Wang F, Yang D, Liu S, Li P et al. Effect of telemedicine intervention on hypoglycaemia in diabetes patients: A systematic review and meta‑analysis of randomised controlled trials. J Telemed Telecare. 2019;25(7):402-13. 26. Snorgaard O, Poulsen GM, Andersen HK, Astrup A. Systematic review and meta‑analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000354. 27. Pai LW, Li TC, Hwu YJ, Chang SC, Chen LL, Chang PY. The effectiveness of regular leisure ‑time physical activities on long‑termglycemic control in people with type 2 diabetes: A systematic review and meta‑analysis. Diabetes Res Clin Pract. 2016;113:77-85. 28. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC. The effect of oral antidiabetic agents on A1C levels: a systematic review and meta‑analysis. Diabetes Care. 2010;33(8):1859-64. 29. Effect of intensive blood‑glucose control withmetformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854-65. 30. Danne T, Limbert C, Puig DomingoM, Del Prato S, Renard E, Choudhary P et al. Telemonitoring, Telemedicine and Time in Range During the Pandemic: ParadigmChange for Diabetes Risk Management in the Post‑COVID Future. Diabetes Ther. 2021;12(9):2289-310. 31. YaronM, Sher B, Sorek D, Shomer M, Levek N, Schiller T et al. A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps. Acta Diabetol. 2019;56(6):667-73. 32. Schlesinger S, Neuenschwander M, Barbaresko J, Lang A, Maalmi H, Rathmann W et al. Prediabetes and risk of mortality, diabetes‑related complications and comorbidities: umbrella review of meta‑analyses of prospective studies. Diabetologia. 2022;65(2):275-85. 33. Mishra K, Edwards B. Cardiac Outpatient Care in a Digital Age: Remote Cardiology Clinic Visits in the Era of COVID-19. Curr Cardiol Rep. 2022. 34. Li JO, LiuH, TingDSJ, Jeon S, Chan RVP, KimJE et al. Digital technology, tele‑medicine and artificial intelligence in ophthalmology: A global perspective. Prog Retin Eye Res. 2021;82:100900. 35. Chen L, Cheng L, Gao W, Chen D, Wang C, Ran X. Telemedicine in Chronic Wound Management: Systematic Review And Meta‑Analysis. JMIR Mhealth Uhealth. 2020;8(6):e15574. 36. Olivia NU, Happiness UC, Obinna OM. Protective effect of Cnidoscolus aconitifolius leaves against diclofenac‑induced gastric mucosal damage. Pak J Pharm Sci. 2020;33(2):651-7. 37. Tchero H, Noubou L, Becsangele B, Mukisi‑Mukaza M, Retali GR, Rusch E. Telemedicine in Diabetic Foot Care: A Systematic Literature Review of Interventions and Meta‑analysis of Controlled Trials. Int J Low ExtremWounds. 2017;16(4):274-83. 38. Lipscomb D, Smith AS, Adamson S, Rezazadeh EM. Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit? Diabet Med. 2020;37(8):1409-10. 39. Fasterholdt I, Gerstrom M, Rasmussen BSB, Yderstraede KB, Kidholm K, Pedersen KM. Cost‑effectiveness of telemonitoring of diabetic foot ulcer patients. Health Informatics J. 2018;24(3):245-58. 40. Appuswamy AV, Desimone ME. Managing Diabetes in Hard to Reach Populations: A Review of Telehealth Interventions. Curr Diab Rep. 2020;20(7):28.
RkJQdWJsaXNoZXIy NDA4Mjc=